Video Experimental Relacionado
Updated: Sep 10, 2025
06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
845
Papel de los polimorfismos genéticos OCT1 y MAP3K5 en la farmacocinética de la hidroxiurea
Sarah Allegra1, Giuliana Abbadessa1, Francesco Chiara1,2
1Clinical Pharmacology, Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043 Turin, Italy.
Life (Basel, Switzerland)
|August 28, 2025
Resumen
Las variaciones genéticas en OCT1 influyen en la semivida del fármaco hidroxiurea en pacientes con anemia falciforme. Esta visión farmacogenética, teniendo en cuenta el sexo y la etnia, podría personalizar el tratamiento para obtener mejores resultados.
Área de la Ciencia:
- Farmacogenética
- La genómica
- Hematología
Sus antecedentes:
- La hidroxiurea es un tratamiento estándar para la enfermedad de células falciformes, pero su eficacia varía significativamente entre las personas.
- Esta variabilidad requiere dosis más altas y puede conducir a una mayor toxicidad.
- Comprender los factores hereditarios es clave para personalizar el tratamiento con hidroxiurea.
Objetivo del estudio:
- Investigar el impacto de los polimorfismos de los genes OCT1 y MAP3K5 en la farmacocinética de la hidroxiurea.
- Explorar las posibles diferencias étnicas y basadas en el sexo en estas influencias genéticas.
Principales métodos:
- Análisis retrospectivo de 79 pacientes con anemia falciforme.
- Genotipado de los polimorfismos OCT1 (rs683369) y MAP3K5 (rs9376230, rs9483947).
Principales resultados:
- El genotipo OCT1 rs683369 GG se asoció con una semivida más corta en pacientes subsaharianos en comparación con el genotipo GC.
- Esta asociación también se observó en pacientes pediátricas subsaharianas.
Conclusiones:
- Las variaciones genéticas, específicamente los polimorfismos OCT1, influyen significativamente en la farmacocinética de la hidroxiurea.
- La consideración del sexo y la etnia es crucial para los estudios farmacogenéticos de la hidroxiurea.
- Estos hallazgos ponen de relieve el potencial de la farmacogenética para mejorar el manejo clínico de la hidroxiurea en la anemia falciforme.
Videos de Conceptos Relacionados
01:27Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91
01:16Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
267
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
267
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
312
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
312
01:14Hepatic Drug Clearance: Role of Transporters
100
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
100